Tower Research Capital (TRC)’s Anixa Biosciences ANIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,799
Closed -$4.17K 5163
2024
Q4
$4.17K Buy
1,799
+316
+21% +$733 ﹤0.01% 4501
2024
Q3
$4.67K Sell
1,483
-4,896
-77% -$15.4K ﹤0.01% 4457
2024
Q2
$14.1K Buy
6,379
+844
+15% +$1.87K ﹤0.01% 3964
2024
Q1
$17.3K Buy
5,535
+2,832
+105% +$8.84K ﹤0.01% 3128
2023
Q4
$10.5K Sell
2,703
-13,060
-83% -$50.7K ﹤0.01% 4239
2023
Q3
$51.5K Buy
15,763
+12,596
+398% +$41.2K ﹤0.01% 2529
2023
Q2
$10.1K Sell
3,167
-226
-7% -$723 ﹤0.01% 4132
2023
Q1
$14K Buy
3,393
+3,190
+1,571% +$13.2K ﹤0.01% 3861
2022
Q4
$1K Buy
+203
New +$1K ﹤0.01% 5542
2022
Q3
Sell
-1,452
Closed -$4K 6030
2022
Q2
$4K Sell
1,452
-4,531
-76% -$12.5K ﹤0.01% 5162
2022
Q1
$16K Buy
5,983
+3,060
+105% +$8.18K ﹤0.01% 3740
2021
Q4
$9K Sell
2,923
-412
-12% -$1.27K ﹤0.01% 4670
2021
Q3
$16K Sell
3,335
-16,644
-83% -$79.9K ﹤0.01% 3910
2021
Q2
$77K Buy
+19,979
New +$77K ﹤0.01% 2634
2021
Q1
Sell
-14,218
Closed -$44K 5367
2020
Q4
$44K Buy
14,218
+10,308
+264% +$31.9K ﹤0.01% 3225
2020
Q3
$10K Sell
3,910
-2,582
-40% -$6.6K ﹤0.01% 4087
2020
Q2
$20K Buy
6,492
+1,330
+26% +$4.1K ﹤0.01% 3668
2020
Q1
$8K Sell
5,162
-955
-16% -$1.48K ﹤0.01% 2103
2019
Q4
$20K Buy
6,117
+5,210
+574% +$17K ﹤0.01% 1906
2019
Q3
$4K Buy
907
+698
+334% +$3.08K ﹤0.01% 3382
2019
Q2
$1K Sell
209
-790
-79% -$3.78K ﹤0.01% 3401
2019
Q1
$5K Sell
999
-373
-27% -$1.87K ﹤0.01% 3036
2018
Q4
$5K Buy
1,372
+253
+23% +$922 ﹤0.01% 2876
2018
Q3
$5K Sell
1,119
-1,547
-58% -$6.91K ﹤0.01% 3095
2018
Q2
$8K Buy
+2,666
New +$8K ﹤0.01% 2865
2016
Q4
Sell
-800
Closed -$3K 3790
2016
Q3
$3K Sell
800
-177
-18% -$664 ﹤0.01% 2809
2016
Q2
$3K Buy
977
+160
+20% +$491 ﹤0.01% 3652
2016
Q1
$2K Buy
817
+718
+725% +$1.76K ﹤0.01% 3316
2015
Q4
$0 Sell
99
-861
-90% ﹤0.01% 4431
2015
Q3
$5K Buy
+960
New +$5K ﹤0.01% 2766